Intensity Therapeutics Enters Material Definitive Agreement
Ticker: INTS · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1567264
| Field | Detail |
|---|---|
| Company | Intensity Therapeutics, Inc. (INTS) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
Intensity Therapeutics signed a major deal on April 24th.
AI Summary
On April 24, 2025, Intensity Therapeutics, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Shelton, CT, filed this 8-K report on April 25, 2025. The filing pertains to an event that occurred on April 24, 2025.
Why It Matters
This filing indicates a significant new contract or partnership for Intensity Therapeutics, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial report.
Key Players & Entities
- Intensity Therapeutics, Inc. (company) — Registrant
- April 24, 2025 (date) — Date of earliest event reported
- April 25, 2025 (date) — Date of report filing
- Delaware (jurisdiction) — State of Incorporation
- Shelton, CT (location) — Principal Executive Offices
FAQ
What type of material definitive agreement did Intensity Therapeutics enter into?
The filing states that Intensity Therapeutics, Inc. entered into a material definitive agreement on April 24, 2025, but does not specify the nature of the agreement.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on April 25, 2025.
What is the principal business of Intensity Therapeutics, Inc.?
Intensity Therapeutics, Inc. is in the business of Biological Products (No Diagnostic Substances), with SIC code 2836.
Where are Intensity Therapeutics, Inc.'s principal executive offices located?
The principal executive offices of Intensity Therapeutics, Inc. are located at 1 Enterprise Drive, Suite 430, Shelton, CT 06484-4779.
What is the Commission File Number for Intensity Therapeutics, Inc.?
The Commission File Number for Intensity Therapeutics, Inc. is 001-41109.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding INTENSITY THERAPEUTICS, INC. (INTS).